PYRIMETHAMINE AS A POTENTIAL PHARMACOLOGICAL CHAPERONE FOR LATE-ONSET FORMS OF GM2 GANGLIOSIDOSIS

Benzer Materyaller

• The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported
  Yazar:: Maegawa, Gustavo H. B., ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
  Yazar:: Clarke, Joe T.R., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy
  Yazar:: Rigat, Brigitte A., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Crystal Structure of β-Hexosaminidase B in Complex with Pyrimethamine, a Potential Pharmacological Chaperone()
  Yazar:: Bateman, Katherine S., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Lending a helping hand, screening chemical libraries for compounds that enhance β-hexosaminidase A activity in GM2 gangliosidosis cells
  Yazar:: Tropak, Michael B., ve diğerleri
  Baskı/Yayın Bilgisi: (2007)